Loughborough, England, Aug. 14, 2023 (GLOBE NEWSWIRE) Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, today released its financial results for the quarter ended June 30, 2023 and provided a business update. Corporate Highlights: Previously announced initial patient data from UK NHS (National Health Servic
England - Nemaura Medical, Inc. , a medical technology company focused on commercializing a daily disposable wearable glucose sensor and supporting personalized digital coaching programs, announces. -Today at 09:41 am- MarketScreener
/PRNewswire/ The wearable patch market is set to grow by USD 5,653.7 million from 2022 to 2027, progressing at a CAGR of 12.02% during the forecast period..
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.